These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24002436)

  • 1. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs.
    Xu Y; Xie Y; Wang X; Chen X; Liu Q; Ying M; Zheng Q
    Oncol Rep; 2013 Nov; 30(5):2056-62. PubMed ID: 24002436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
    J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
    Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
    Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of side population cells in human malignant mesothelioma cell lines.
    Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
    Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
    Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
    BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
    Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
    J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
    Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
    Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
    Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
    Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].
    Zhao Y; Jia HL; Zhou HJ; Dong QZ; Fu LY; Yan ZW; Sun J; Ren N; Ye QH; Qin LX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):526-30. PubMed ID: 19912688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
    Zhou J; Wang W
    J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.